Preferences
Related Series
Related Segments
Related Articles
Global (Non-US) EMR Market Share 2023
Europe Continues to Lead, Energy Picking Up in Other Regions
With the pandemic mostly past, healthcare organizations across the world are readdressing key technology priorities. EMR initiatives continue to be prioritized at most organizations. In 2022, KLAS validated 164 EMR purchase decisions impacting 532 hospitals and over 82,000 beds. 30 different vendors in 31 different countries were selected. While 2022 had the lowest validated EMR purchase activity of the last five years, certain markets remained highly active—specifically, Europe and Latin America and, to a lesser extent, Asia and the Middle East. Canada and Oceania, while relatively quiet in 2022, are poised for significant activity in 2023 due to major contracts on the horizon.
If you don't have a login, getting started is easy.
Key Findings:
- Dedalus, Oracle Health (Cerner), IQVIA Lead Multiregional Vendors in 2022 Wins
- Softway Medical Leads a Strong Year for Regional Vendors, Followed by CGM & System C in Europe, MV & Philips in Latin America
- Europe: Regional Decisions Bolster Softway Medical, Dedalus & CGM
- Latin America: MV Leads in Brazil Decisions, Followed by Philips; NTT DATA Selected in Argentina
- Middle East/Africa: Oracle Health (Cerner) Selections Boost Already Strong Presence, Dedalus Selected in Morocco
- Asia/Oceania: IQVIA, InterSystems, ezCaretech Most Widely Selected as EMR Activity Rebounds
- Canada: Oracle Health (Cerner) Selected in the Only 2022 Hospital EMR Decision
Writer
Amanda Wind Smith
Designer
Natalie Jamison
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.